Table 2.
Characteristic | Value (n=29) |
---|---|
Age, yr | 62 (50–71) |
Sex | |
Male | 23 (79) |
Female | 6 (21) |
Familial adenomatous polyposis | 5 (17) |
Duct involvement | |
Common bile duct | 14 (48) |
Pancreatic duct | 1 (3) |
Common bile duct+pancreatic duct | 14 (48) |
Pathology on specimen of ESP | |
TA-LGD | 17 (59) |
TA-HGD | 3 (10) |
TV-LGD | 4 (14) |
TV-HGD | 5 (17) |
Longest diameter of adenoma, mm | 14 (10–19) |
Margin involvement on specimen of ESP, deep margin/latera margin | |
Negative/negative | 16 (55) |
Positive/negative | 6 (21) |
Negative/positive | 2 (7) |
Positive/positive | 1 (3) |
Indeterminate* | 4 (14) |
Detection of intraductal lesion | |
Same session of ESP | 5 (17) |
Remnant lesion after ESP | 14 (48) |
Recurrent lesion after ESP | 10 (34) |
Follow-up duration, day | 776 (470–984) |
Data are presented as median (interquartile range) or number (%).
ESP, endoscopic snare papillectomy; TA, tubular adenoma; TV, tubulovillous adenoma; LGD, low-grade dysplasia; HGD, high-grade dysplasia.
*Margin involvement could not be evaluated due to severe squeezing artifacts and cauterization artifacts of the resected specimens.